Bellerophon Therapeutics (BLPH) Momentum In a Row; Luna Innovations (LUNA) Greenlights Share Buyback Plan
The price of Bellerophon Therapeutics, Inc. (Nasdaq:BLPH) stock continued an impressive upward move for second day in a row on no news, touching the $4.58 mark during Thursday’s trading session and finally closing at $3.01, up $1.04 (or +52.79%) with a total volume of 6,105,011 shares traded, representing a large increase in activity versus its average volume (3m) of 22,131
A month ago, the clinical-stage biotherapeutics company reported that its first quarter 2016 net loss decreased by 45% to ($7.1) million from ($12.9) million in the same period the prior year
Bellerophon Therapeutics, which focuses on developing innovative products combining novel drugs and devices in the treatment of cardiopulmonary diseases, has 13.48M Shares Outstanding, Market Capitalization (intraday) of $40.56M and BLPH stock 52-week range is from $1.09 to $9.40 per share
Luna Innovations Inc. (Nasdaq:LUNA) shares closed in positive territory by 3.67% (or +0.04) at $1.13 on Thursday.
After the closing bell, the optical technology company said that its board has approved a stock buyback program of up to $2 million, sending its shares up in extended trading
Luna Innovations, which develops high speed optics and high performance fiber optic test products, has 27.48M Shares Outstanding, Market Capitalization (intraday) of $31.05M and LUNA stock one-year range is between $0.74 and $1.30 per share
Disclaimer: The disclaimer is to be read and fully understood before using our site, or joining our email list. GalaxyStocks is not a registered investment adviser. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Investors should always conduct their own due diligence with any potential investment, with independent research and other professional advice. Read full disclaimer at http://galaxystocks.com/disclaimer/